Skip to content

Integrated care for inflammatory bowel disease patients in the Netherlands with the novel telemedicine tool myIBDcoach: a randomized controled trial

Integrated care for inflammatory bowel disease patients in the Netherlands with the novel telemedicine tool myIBDcoach: a randomized controled trial - The myIBDcoach trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON41419
Enrollment
1000
Registered
2014-07-25
Start date
2014-08-11
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Crohn's disease ulcerative colitis

Interventions

Patients will be randomized between 2 arms 1. Standard-care: 2. IBD-coach arm: patients are followed with the telemedicine tool myIBDcoach and one standard appointment after one year. Patients in b

Sponsors

Universiteit Maastricht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - diagnosis confirmed Crohn's disease or ulcerative colitis - age between 18 and 75 - Patient has/can use a computer or tabloid or smart phone with a connection to the internet

Exclusion criteria

Exclusion criteria: - Patients who do not speek Dutch - Patient discharged from the hospital within 2 week prior to baseline

Design outcomes

Primary

MeasureTime frame
Primary endpoints: Difference between study arms REGARDING: * Visits to the outpatient clinic * Patient satisfaction with IBD health care

Secondary

MeasureTime frame
Secondary endpoints: Difference between study arms REGARDING: * Complications (hospital admissions, duration of hospital admission, need for steroid use) * Compliance * Patient reported quality of care * Medication adherence * Self-efficacy * Quality of life * Knowledge about the disease and treatment * Disease activity: amount of flares, mean relapse duration * Consumption of healthcare * Smoking

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)